ESG initiatives are increasingly prioritized by Asia Pacific medtech companies and their customers, according to a survey conducted jointly by Bain & Company and Asia Pacific Medical Technology Association (APACMed). The survey, which was completed in May and included 120 customers and over 800 employees and executives from medtech companies across six Asia Pacific markets found that more than 70% of medtech customers had already defined Environmental, social, and governance (ESG) strategies, 60% of medtech employees reported that their companies have established ESG ambitions and had set specific targets.